"In health care, major drug makers have sought to collaborate with health tech up-and-comers. And on the surface, there’s good reason to think that these partnerships can translate into products that can benefit human health. But the reality is that the interests of the two parties do not always align. advertisement The latest example comes..." Lire la suite
What Sanofi’s withdrawal from diabetes tech tells us about digital health
Statnews, 11/12/2019
Partagé par :
Beesens Teams
